• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VHPKQHR肽修饰的超小顺磁性氧化铁纳米颗粒靶向类风湿性关节炎用于T加权磁共振成像

VHPKQHR Peptide Modified Ultrasmall Paramagnetic Iron Oxide Nanoparticles Targeting Rheumatoid Arthritis for T-Weighted Magnetic Resonance Imaging.

作者信息

Zhang Chunyu, Huang Wentao, Huang Chen, Zhou Chengqian, Tang Yukuan, Wei Wei, Li Yongsheng, Tang Yukuan, Luo Yu, Zhou Quan, Chen Wenli

机构信息

MOE Key Laboratory of Laser Life Science, Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou, China.

Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou, China.

出版信息

Front Bioeng Biotechnol. 2022 Feb 28;10:821256. doi: 10.3389/fbioe.2022.821256. eCollection 2022.

DOI:10.3389/fbioe.2022.821256
PMID:35295653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8918785/
Abstract

Magnetic resonance imaging (MRI) could be the ideal diagnostic modality for early rheumatoid arthritis (RA). Vascular cell adhesion molecule-1 (VCAM-1) is highly expressed in synovial locations in patients with RA, which could be a potential target protein for RA diagnosis. The peptide VHPKQHR (VHP) has a high affinity to VCAM-1. To make the contrast agent to target RA at an early stage, we used VHP and ultrasmall paramagnetic iron oxide (USPIO) to synthesize UVHP (U stands for USPIO) through a chemical reaction with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide. The size of UVHP was 6.7 nm; the potential was -27.7 mV, and the / value was 1.73. Cytotoxicity assay exhibited that the cell survival rate was higher than 80% at even high concentrations of UVHP (Fe concentration 200 µg/mL), which showed the UVHP has low toxicity. Compared with no TNF-α stimulation, VCAM-1 expression was increased nearly 3-fold when mouse aortic endothelial cells (MAECs) were stimulated with 50 ng/mL TNF-α; cellular Fe uptake was increased very significantly with increasing UVHP concentration under TNF-α treatment; cellular Fe content was 17 times higher under UVHP with Fe concentration 200 µg/mL treating MAECs. These results indicate that UVHP can target overexpression of VCAM-1 at the cellular level. RA mice models were constructed with adjuvant-induced arthritis. MRI and biodistribution results show that the signal intensity of knee joints was increased significantly and Fe accumulation in RA model mice compared with normal wild-type mice after injecting UVHP 24 h. These results suggest that we have synthesized a simple, low-cost, and less toxic contrast agent UVHP, which targeted VCAM-1 for early-stage RA diagnosis and generates high contrast in T-weighted MRI.

摘要

磁共振成像(MRI)可能是早期类风湿性关节炎(RA)的理想诊断方式。血管细胞黏附分子-1(VCAM-1)在RA患者的滑膜部位高表达,这可能是RA诊断的潜在靶蛋白。肽VHPKQHR(VHP)对VCAM-1具有高亲和力。为了使造影剂在早期靶向RA,我们使用VHP和超小顺磁性氧化铁(USPIO)通过与1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐和N-羟基琥珀酰亚胺的化学反应合成了UVHP(U代表USPIO)。UVHP的尺寸为6.7纳米;电位为-27.7毫伏,ζ/电位值为1.73。细胞毒性试验表明,即使在高浓度的UVHP(铁浓度为200微克/毫升)下,细胞存活率仍高于80%,这表明UVHP具有低毒性。与未用肿瘤坏死因子-α(TNF-α)刺激相比,当用50纳克/毫升TNF-α刺激小鼠主动脉内皮细胞(MAECs)时,VCAM-1表达增加了近3倍;在TNF-α处理下,随着UVHP浓度的增加,细胞铁摄取显著增加;在铁浓度为200微克/毫升的UVHP处理MAECs时,细胞铁含量高出17倍。这些结果表明,UVHP可以在细胞水平上靶向VCAM-1的过表达。用佐剂诱导的关节炎构建RA小鼠模型。MRI和生物分布结果表明,注射UVHP 24小时后,与正常野生型小鼠相比,RA模型小鼠膝关节的信号强度显著增加,铁蓄积。这些结果表明,我们合成了一种简单、低成本且毒性较小的造影剂UVHP,其靶向VCAM-1用于早期RA诊断,并在T加权MRI中产生高对比度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/d81ca374bafd/fbioe-10-821256-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/2adbaeb230c6/fbioe-10-821256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/ae4c69df6b71/fbioe-10-821256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/923929cd4dda/fbioe-10-821256-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/70b80f2960ac/fbioe-10-821256-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/77887bbffd76/fbioe-10-821256-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/d81ca374bafd/fbioe-10-821256-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/2adbaeb230c6/fbioe-10-821256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/ae4c69df6b71/fbioe-10-821256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/923929cd4dda/fbioe-10-821256-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/70b80f2960ac/fbioe-10-821256-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/77887bbffd76/fbioe-10-821256-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/8918785/d81ca374bafd/fbioe-10-821256-g006.jpg

相似文献

1
VHPKQHR Peptide Modified Ultrasmall Paramagnetic Iron Oxide Nanoparticles Targeting Rheumatoid Arthritis for T-Weighted Magnetic Resonance Imaging.VHPKQHR肽修饰的超小顺磁性氧化铁纳米颗粒靶向类风湿性关节炎用于T加权磁共振成像
Front Bioeng Biotechnol. 2022 Feb 28;10:821256. doi: 10.3389/fbioe.2022.821256. eCollection 2022.
2
T1-weighted MRI of targeting atherosclerotic plaque based on CD40 expression on engulfed USPIO's cell surface.基于吞噬超顺磁性氧化铁纳米颗粒(USPIO)细胞表面CD40表达的靶向动脉粥样硬化斑块的T1加权磁共振成像。
Biomed Mater. 2024 Jan 25;19(2). doi: 10.1088/1748-605X/ad1df6.
3
Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy.靶向肽、荧光试剂修饰的包裹雷帕霉素的磁性脂质体靶向早期动脉粥样硬化斑块并进行治疗。
Pharmaceutics. 2022 May 18;14(5):1083. doi: 10.3390/pharmaceutics14051083.
4
Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium.筛选靶向白细胞介素-7受体α的肽用于类风湿性关节炎滑膜的分子成像
Arthritis Res Ther. 2016 Oct 12;18(1):230. doi: 10.1186/s13075-016-1133-8.
5
Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.基于超顺磁性氧化铁(USPIO)的脂质体作为磁共振成像探针。
Int J Nanomedicine. 2012;7:2349-59. doi: 10.2147/IJN.S30617. Epub 2012 May 9.
6
[Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].[RGD10-NGR9双靶点超顺磁性氧化铁的构建及其在裸鼠体内的磁共振成像特征]
Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):808-13.
7
Detection of vascular cell adhesion molecule-1 expression with USPIO-enhanced molecular MRI in a mouse model of cerebral ischemia.应用超顺磁性氧化铁增强分子 MRI 检测脑缺血模型中血管细胞黏附分子-1 的表达。
Contrast Media Mol Imaging. 2013 Mar-Apr;8(2):157-64. doi: 10.1002/cmmi.1512.
8
Specific E-selectin targeting with a superparamagnetic MRI contrast agent.使用超顺磁性磁共振成像造影剂对E-选择素进行特异性靶向
Contrast Media Mol Imaging. 2006 Jan-Feb;1(1):15-22. doi: 10.1002/cmmi.87.
9
In Vitro and In Vivo Detection of Drug-induced Apoptosis Using Annexin V-conjugated Ultrasmall Superparamagnetic Iron Oxide (USPIO): A Pilot Study.应用阿霉素偶联超顺磁性氧化铁纳米颗粒(USPIO)体外和体内检测药物诱导的细胞凋亡:一项初步研究。
Magn Reson Med Sci. 2019 Apr 10;18(2):142-149. doi: 10.2463/mrms.mp.2017-0157. Epub 2018 Oct 2.
10
Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.小鼠淋巴管内皮细胞靶向探针:抗 LYVE-1 抗体的磁性纳米颗粒。
Int J Nanomedicine. 2013;8:2273-84. doi: 10.2147/IJN.S45817. Epub 2013 Jun 21.

引用本文的文献

1
Formulation and Evaluation of VCAM-1-Targeted Methotrexate Lipid Nanoparticles for Rheumatoid Arthritis Therapy.用于类风湿性关节炎治疗的靶向血管细胞黏附分子-1的甲氨蝶呤脂质纳米粒的制备与评价
Int J Nanomedicine. 2025 Sep 8;20:10977-10998. doi: 10.2147/IJN.S532163. eCollection 2025.
2
Mesoporous Polydopamine Nanotherapeutics for MRI-Guided Cancer Photothermal and Anti-Inflammatory Therapy.介孔聚多巴胺纳米治疗剂用于 MRI 引导的癌症光热和抗炎治疗。
Int J Nanomedicine. 2024 Oct 25;19:10819-10837. doi: 10.2147/IJN.S467419. eCollection 2024.
3
Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.

本文引用的文献

1
Single 808 nm near-infrared-triggered multifunctional upconverting phototheranostic nanocomposite for imaging-guided high-efficiency treatment of tumors.单根 808nm 近红外触发多功能上转换光热诊疗纳米复合材料用于肿瘤的成像引导高效治疗。
J Biophotonics. 2021 Sep;14(9):e202100134. doi: 10.1002/jbio.202100134. Epub 2021 Jun 22.
2
MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.MnDPDP:用于成像和保护存活组织的造影剂。
Contrast Media Mol Imaging. 2020 Sep 4;2020:3262835. doi: 10.1155/2020/3262835. eCollection 2020.
3
A cation exchange strategy to construct a targeting nanoprobe for enhanced -weighted MR imaging of tumors.
纳米技术助力的类风湿关节炎联合治疗:原理、策略与挑战。
J Nanobiotechnology. 2024 Jul 22;22(1):431. doi: 10.1186/s12951-024-02670-7.
4
Comparative transcriptomics revealed neurodevelopmental impairments and ferroptosis induced by extremely small iron oxide nanoparticles.比较转录组学揭示了极小微粒氧化铁纳米颗粒诱导的神经发育损伤和铁死亡。
Front Genet. 2024 May 17;15:1402771. doi: 10.3389/fgene.2024.1402771. eCollection 2024.
5
Role and uptake of metal-based nanoconstructs as targeted therapeutic carriers for rheumatoid arthritis.金属基纳米结构作为类风湿性关节炎靶向治疗载体的作用与应用
3 Biotech. 2024 May;14(5):142. doi: 10.1007/s13205-024-03990-z. Epub 2024 Apr 29.
一种构建用于肿瘤增强加权磁共振成像的靶向纳米探针的阳离子交换策略。
J Mater Chem B. 2020 Sep 30;8(37):8519-8526. doi: 10.1039/d0tb01632b.
4
Iron Oxide Nanoparticles as T Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives.氧化铁纳米颗粒作为磁共振成像的 T 对比剂:基础、挑战、应用和前景。
Adv Mater. 2021 Jun;33(23):e1906539. doi: 10.1002/adma.201906539. Epub 2020 Jun 4.
5
[T-weighted magnetic resonance imaging contrast agents and their theranostic nanoprobes].[T加权磁共振成像造影剂及其诊疗纳米探针]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Mar 30;40(3):427-444. doi: 10.12122/j.issn.1673-4254.2020.03.24.
6
Folic acid-conjugated glucose and dextran coated iron oxide nanoparticles as MRI contrast agents for diagnosis and treatment response of rheumatoid arthritis.叶酸偶联葡萄糖和葡聚糖包被的氧化铁纳米颗粒作为类风湿关节炎诊断及治疗反应的磁共振成像造影剂
J Mater Chem B. 2014 Apr 28;2(16):2240-2247. doi: 10.1039/c3tb21732a. Epub 2014 Mar 13.
7
and experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements.并进行实验以评估超小氧化铁纳米颗粒的生物分布和细胞毒性,这些纳米颗粒有可能被用作口服铁补充剂。
Nanotoxicology. 2020 Apr;14(3):388-403. doi: 10.1080/17435390.2019.1710613. Epub 2020 Jan 20.
8
Biocompatibility assessment of sub-5 nm silica-coated superparamagnetic iron oxide nanoparticles in human stem cells and in mice for potential application in nanomedicine.用于纳米医学潜在应用的亚 5nm 硅烷化超顺磁性氧化铁纳米颗粒在人干细胞和小鼠中的生物相容性评估。
Nanoscale. 2020 Jan 23;12(3):1759-1778. doi: 10.1039/c9nr09683c.
9
Light-Addressable Nanoclusters of Ultrasmall Iron Oxide Nanoparticles for Enhanced and Dynamic Magnetic Resonance Imaging of Arthritis.用于增强型和动态磁共振成像关节炎的超小氧化铁纳米颗粒的光寻址纳米团簇
Adv Sci (Weinh). 2019 Aug 8;6(19):1901800. doi: 10.1002/advs.201901800. eCollection 2019 Oct 2.
10
Gadolinium-conjugated CB86: a novel TSPO-targeting MRI contrast agent for imaging of rheumatoid arthritis.钆共轭CB86:一种用于类风湿性关节炎成像的新型靶向转运体18 kDa外周苯二氮䓬受体的磁共振成像造影剂
J Drug Target. 2020 Apr;28(4):398-407. doi: 10.1080/1061186X.2019.1669040. Epub 2019 Nov 12.